These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
491 related items for PubMed ID: 23146493
1. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients. Bodro M, Sabé N, Gomila A, Ayats J, Baliellas C, Roca J, Melilli E, Carratalà J. Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493 [Abstract] [Full Text] [Related]
2. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Neofytos D, Fishman JA, Horn D, Anaissie E, Chang CH, Olyaei A, Pfaller M, Steinbach WJ, Webster KM, Marr KA. Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459 [Abstract] [Full Text] [Related]
3. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Bodro M, Sabé N, Tubau F, Lladó L, Baliellas C, Roca J, Cruzado JM, Carratalà J. Transplantation; 2013 Nov 15; 96(9):843-9. PubMed ID: 23883973 [Abstract] [Full Text] [Related]
4. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant. Alexander BD, Perfect JR, Daly JS, Restrepo A, Tobón AM, Patino H, Hardalo CJ, Graybill JR. Transplantation; 2008 Sep 27; 86(6):791-6. PubMed ID: 18813103 [Abstract] [Full Text] [Related]
6. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Fernàndez-Sabé N, Cervera C, Fariñas MC, Bodro M, Muñoz P, Gurguí M, Torre-Cisneros J, Martín-Dávila P, Noblejas A, Len O, García-Reyne A, Del Pozo JL, Carratalà J. Clin Infect Dis; 2012 Feb 01; 54(3):355-61. PubMed ID: 22075795 [Abstract] [Full Text] [Related]
7. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K. Clin Infect Dis; 2009 Feb 01; 48(3):265-73. PubMed ID: 19115967 [Abstract] [Full Text] [Related]
8. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA, Kwak EJ, Paterson DL. Clin Infect Dis; 2007 May 15; 44(10):1307-14. PubMed ID: 17443467 [Abstract] [Full Text] [Related]
11. Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control study. Fernàndez-Sabé N, Cervera C, López-Medrano F, Llano M, Sáez E, Len O, Fortún J, Blanes M, Laporta R, Torre-Cisneros J, Gavaldà J, Muñoz P, Fariñas MC, María Aguado J, Moreno A, Carratalà J. Clin Infect Dis; 2009 Oct 15; 49(8):1153-9. PubMed ID: 19751149 [Abstract] [Full Text] [Related]
13. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients. Ha YE, Joo EJ, Park SY, Wi YM, Kang CI, Chung DR, Joh JW, Lee SK, Song JH, Peck KR. Transpl Infect Dis; 2012 Dec 15; 14(6):626-34. PubMed ID: 22372581 [Abstract] [Full Text] [Related]
14. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. Fortún J, Martín-Davila P, Moreno S, Barcena R, de Vicente E, Honrubia A, García M, Nuño J, Candela A, Uriarte M, Pintado V. J Antimicrob Chemother; 2003 Nov 15; 52(5):813-9. PubMed ID: 14563893 [Abstract] [Full Text] [Related]
16. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Peleg AY, Husain S, Kwak EJ, Silveira FP, Ndirangu M, Tran J, Shutt KA, Shapiro R, Thai N, Abu-Elmagd K, McCurry KR, Marcos A, Paterson DL. Clin Infect Dis; 2007 Jan 15; 44(2):204-12. PubMed ID: 17173218 [Abstract] [Full Text] [Related]
17. Inadequate antibiotic therapy in solid organ transplant recipients is associated with a higher mortality rate. Lupei MI, Mann HJ, Beilman GJ, Oancea C, Chipman JG. Surg Infect (Larchmt); 2010 Feb 15; 11(1):33-9. PubMed ID: 19785562 [Abstract] [Full Text] [Related]
18. Clinical features and outcomes of tuberculosis in solid organ transplant recipients. Bodro M, Sabé N, Santín M, Cruzado JM, Lladó L, González-Costello J, Carratalà J. Transplant Proc; 2012 Nov 15; 44(9):2686-9. PubMed ID: 23146494 [Abstract] [Full Text] [Related]
20. Infections related to renal transplantation requiring intensive care admission: a 20-year study. Mouloudi E, Massa E, Georgiadou E, Iosifidis E, Katsika E, Rembelakos G, Gakis D, Imvrios G, Papanikolaou V, Papadopoulos S, Gritsi-Gerogianni N. Transplant Proc; 2012 Nov 15; 44(9):2721-3. PubMed ID: 23146504 [Abstract] [Full Text] [Related] Page: [Next] [New Search]